UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Favipiravir not approved as new coronavirus drug yet’
by Kim Yun-mi
2020-02-21 12:08
Closures of emergency rooms could hit critical patients hard
by Kim Yun-mi
2020-02-20 14:25
Regulator pushed voluntary recall of Belviq without data review
by Kim Yun-mi
2020-02-19 11:52
Remdesivir, plasma transfusion emerge as treatment of new coronavirus
by Kim Yun-mi
2020-02-18 12:57
International conferences put back due to coronavirus outbreak
by Kim Yun-mi
2020-02-13 14:22
라인
Korea University analyzes 5,000 cancer patients’ genomic data
by Kim Yun-mi
2020-02-11 15:49
MSD Korea workers unhappy with spinoff plan
by Kim Yun-mi
2020-02-11 14:57
Fake news about new coronavirus drug candidate goes viral
by Kim Yun-mi
2020-02-11 12:33
New coronavirus causes less damage, spreads more easily
by Kim Yun-mi
2020-02-10 12:32
Experts caution against hasty use of Olumiant for new coronavirus
by Kim Yun-mi
2020-02-06 16:08
라인
MSD to spin off women’s health, biosimilars under new firm
by Kim Yun-mi
2020-02-06 13:07
Interferon, Kaletra to get insurance benefit for new coronavirus treatment
by Kim Yun-mi
2020-02-04 16:39
‘Gilead’s drug candidate effective to fight new coronavirus’
by Kim Yun-mi
2020-02-04 16:39
Merck Korea worker commits suicide
by Kim Yun-mi
2020-01-30 16:09
Astellas’ rheumatoid arthritis drug Smyraf wins regulatory nod
by Kim Yun-mi
2020-01-30 14:07
라인
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’
by Kim Yun-mi
2020-01-29 14:00
Afstyla wins nod as new therapy for hemophilia A
by Kim Yun-mi
2020-01-24 08:18
SK Chemicals avoids drug price cut using administrative suit
by Kim Yun-mi
2020-01-23 15:24
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019
by Kim Yun-mi
2020-01-22 15:10
Some Merck Korea workers commute from provinces to Seoul every day
by Kim Yun-mi
2020-01-21 14:21
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top